CLASS II Drug recall · Reported 5 Nov 2014 · FDA Enforcement Report

Emtriva (emtricitabine) Oral Solution, 10 mg/mL recalled

Gilead Sciences is recalling Emtriva (emtricitabine) Oral Solution, 10 mg/mL, distributed in Puerto Rico. The recall was initiated on 1 Oct 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesFG Lot Number: HDNTD1 and HDNTD exp 30-Jun-15, KCMGD and KCMGD1 exp 31-Oct-15, KYGHA, KYGKA and KYGKK exp 30-Apr-16, MZVBA and MZTZA exp 31-Oct-16
Quantity recalled6,290 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0045-2015
FDA event ID
69411
Recalling firm
Gilead Sciences, Foster City, CA
Classification
Class II
Status
Terminated
Recall initiated
1 Oct 2014
FDA classified
24 Oct 2014
Reported
5 Nov 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

1 Oct 2014Recall initiated by company
24 Oct 2014Classified by FDA+23 days
5 Nov 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container; leaking around the cap

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.

Where it was distributed

United States, Puerto Rico, Fiji.

Puerto Rico

Questions about this recall

Why was it recalled?

Defective Container; leaking around the cap

Which lots are affected?

FG Lot Number: HDNTD1 and HDNTD exp 30-Jun-15, KCMGD and KCMGD1 exp 31-Oct-15, KYGHA, KYGKA and KYGKK exp 30-Apr-16, MZVBA and MZTZA exp 31-Oct-16

Where was it sold?

United States, Puerto Rico, Fiji.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 3 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Gilead Sciences

All 7